Quarterly ResultMay 7, 2026, 05:22 PM
Beauty Health Q1 Net Sales $64.9M; Net Loss $(6.6M)
AI Summary
Beauty Health reported Q1 2026 net sales of $64.91 million, a decrease from the prior year, but significantly improved its net loss to $(6.63) million and operating loss to $(1.80) million. The company also repurchased $21.3 million of its 2026 Convertible Senior Notes, resulting in a $1.0 million gain. Updates were provided on ongoing legal proceedings, including a settlement-in-principle reached for the Customer Class Action.
Key Highlights
- Net sales for Q1 2026 were $64.91 million, down from $69.58 million in Q1 2025.
- Net loss for Q1 2026 improved to $(6.63) million from $(10.10) million in Q1 2025.
- Basic net loss per share for Q1 2026 was $(0.05), an improvement from $(0.08) in Q1 2025.
- Operating loss significantly improved to $(1.80) million in Q1 2026 from $(12.02) million in Q1 2025.
- The company repurchased $21.3 million principal amount of its 2026 Notes for $20.2 million, recognizing a $1.0 million gain.
- Cash, cash equivalents, and restricted cash decreased to $204.36 million at March 31, 2026, from $232.67 million at December 31, 2025.
- Total assets decreased to $473.23 million at March 31, 2026, from $499.80 million at December 31, 2025.
- Total liabilities decreased to $417.99 million at March 31, 2026, from $438.75 million at December 31, 2025.
Price Impact
More from SKIN